Skip to main content
Nucleic Acids Research logoLink to Nucleic Acids Research
. 2019 Mar 27;47(10):5341–5355. doi: 10.1093/nar/gkz218

Deletion of Gtpbp3 in zebrafish revealed the hypertrophic cardiomyopathy manifested by aberrant mitochondrial tRNA metabolism

Danni Chen 1,2,3, Zengming Zhang 1,2,3, Chao Chen 1,2, Shihao Yao 1,2, Qingxian Yang 1,2, Feng Li 1,2, Xiao He 1,2, Cheng Ai 1,2, Meng Wang 1,2,, Min-Xin Guan 1,2,3,4,5,
PMCID: PMC6547414  PMID: 30916346

Abstract

GTPBP3 is a highly conserved tRNA modifying enzyme for the biosynthesis of τm5U at the wobble position of mitochondrial tRNAGlu, tRNAGln, tRNALys, tRNATrp and tRNALeu(UUR). The previous investigations showed that GTPBP3 mutations were associated with hypertrophic cardiomyopathy (HCM). However, the pathophysiology of GTPBP3 deficiency remains elusively. Using the gtpbp3 knockout zebrafish generated by CRISPR/Cas9 system, we demonstrated the aberrant mitochondrial tRNA metabolism in gtpbp3 knock-out zebrafish. The deletion of gtpbp3 may alter functional folding of tRNA, indicated by conformation changes and sensitivity to S1-mediated digestion of tRNAGlu, tRNALys, tRNATrp and tRNALeu(UUR). Strikingly, gtpbp3 knock-out zebrafish displayed the global increases in the aminoacylated efficiencies of mitochondrial tRNAs. The aberrant mitochondrial tRNA metabolisms impaired mitochondrial translation, produced proteostasis stress and altered activities of respiratory chain complexes. These mitochondria dysfunctions caused the alterations in the embryonic heart development and reduced fractional shortening of ventricles in mutant zebrafish. Notably, the gtpbp3 knock-out zebrafish exhibited hypertrophy of cardiomyocytes and myocardial fiber disarray in ventricles. These cardiac defects in the gtpbp3 knock-out zebrafish recapitulated the clinical phenotypes in HCM patients carrying the GTPBP3 mutation(s). Our findings highlight the fundamental role of defective nucleotide modifications of tRNAs in mitochondrial biogenesis and their pathological consequences in hypertrophic cardiomyopathy.

INTRODUCTION

Transfer RNA (tRNA) molecules from all living organisms contain modified nucleotides, which are derivatives of four nucleotides adenosine (A), guanosine (G), uridine (U) and cytidine (C). To date, more than 110 species of modifications have been identified in tRNAs from various organisms (1,2). These modified nucleotides play critical roles in the structure and function of tRNAs, including the stabilization of anticodon structure, codon recognition at the decoding site of small rRNA and the improvement of reading frame maintenance (3–8). Of these, the nucleotide at position 34 (wobble position of anticodon) of tRNA is more prone to be modified than those at other positions of tRNAs (5,9,10). In Escherichia coli, the uridine at position 34 of tRNA is always modified, specifically, the nucleoside 5-methyl-aminomethy-2-thio-uridine (mnm5s2U34) occurs at the wobble position 34 of bacterial tRNAGlu, tRNALys and tRNAGln (11,12). The nucleotides at position 34 of mammalian mitochondrial tRNAs carry the diverse species of modifications including 5-formylcytidine (f5C), 5-taurinomethyluridine (τm5U) and 5-taurinomethyl-2-thiouridine (τm5s2U) (4,13–16). The biosynthesis of τm5s2U modification was catalyzed by highly conserved tRNA modifying enzymes GTPBP3, MTO1 and TRMU (14,17–19). In human mitochondrion, MTO1 and GTPBP3 are involved in the formation of the 5-taurinomethyl group of tRNAGlu, tRNAGln, tRNALys, tRNATrp and tRNALeu(UUR), while TRMU catalyzes the thiolation at position 2 of U34 in tRNAGlu, tRNAGln, tRNALys (17,19–23).

The deficient modifications at U34 of mitochondrial tRNAs have been linked to human diseases (10,23–25). The defective τm5U of tRNALeu(UUR) was responsible for mitochondrial encephalopathy lactic acidosis and stroke-like episodes (MELAS), while the loss of τm5s2U of tRNALys was associated with myoclonic epilepsy associated with ragged red fibers (MERRF) (26–27). The deficient τm5s2U modification caused by mutations in the TRMU and MTO1 genes were responsible for mitochondrial dysfunctions leading to clinical phenotypes, including deafness, reversible infantile liver failure, hypertrophic cardiomyopathy, and lactic acidosis (28–31). In particular, GTPBP3 deficiency was associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy (32–34). The inactivation of GTPBP3 in human cell lines led to the deficient taurine modification at U34 in mitochondrial tRNAGlu, tRNAGln, tRNALys, tRNATrp and tRNALeu(UUR), reduced efficiency of mitochondrial translation and the deficiency of OXPHOS (14,32,35). Furthermore, the defective τm5U34 modification and mitochondrial translations were observed in mutant cell lines carrying the GTPBP3 mutations, derived from patients of families with hypertrophic cardiomyopathy (HCM) characterized by myocardial and myocyte hypertrophy in left ventricle (14,32). However, the lack of animal disease model makes the pathophysiology of GTPBP3 deficiency elusively. In our previous investigation, gtpbp3 knockdown zebrafish embryos displayed the marked decrease of mitochondrial ATP generation and defective development (36). To further investigate the pathophysiology of GTPBP3 deficiency, we generated a gtpbp3ko zebrafish model produced by genome editing using the CRISPR/Cas9 system. First, the gtpbp3ko zebrafish was assessed for the in vivo effects of defective gtpbp3 on mitochondrial tRNA metabolism, mitochondrial translation, proteostasis stress and enzymatic activities of electron transport chain complexes. The gtpbp3ko zebrafish was further evaluated for the effect on cardiac function including cardiac looping and ventricular fractional shortening, the size of cardiomyocyte, the expression of the cardiac natriuretic peptides as well as the ultrastructure of cardiac myofibrils.

MATERIALS AND METHODS

Experimental fish and maintenance

AB wild-type strain and myocardium-specific transgenic Tg (cmlc2: egfp) zebrafish (Danio rerio) were used for this investigation. The animal protocols used in this investigation were approved by the Zhejiang University Institutional Animal Care and Use Committee. All fish were kept in recirculating water at 28°C and fed with commercial pellets at a daily ration of 0.7% of their body weight. Embryos were reared at 28.5°C according to standard protocols (37). Embryos were staged by hours post fertilization (hpf) and days post fertilization (dpf) (38).

Gtpbp3-Knockout zebrafish line generation by CRISPR/Cas9 system

The zCas9 expression plasmid pSP6–2sNLS-spCas9 was linearized by Xba I and used as a template for Cas9 mRNA in vitro synthesis with mMESSAGE mMACHINE mRNA transcription synthesis kits (Ambion). The sequence of sgRNAs was designed according to criteria as described previously (39). The gRNA transcription plasmid was pT7-gRNA. We used the CRISPR/Cas9 design tool (http://zifit.partners.org) to select specific targets to minimize off-target effects. Cas9-encoding mRNA (300 ng/μl) and gRNA (200 ng/μl) were co-injected into one-cell-stage wild-type embryos. Injected embryos were incubated at 28.5°C, and collected for making genomic DNA for genotyping at 50 hpf. Genomic DNA of the 50 hpf injected embryo was used as template to amplify gtpbp3 gene by using the following two primers: F1: GTTGTTGTTTGAGGAGAA; R1: TAAAAGACTGGAGCATTG. The fragments were cloned by using the TA Cloning Kit (TAKARA) and then were sequenced.

Mitochondrial tRNA analysis

Total RNAs were isolated from fish using Totally RNA™ Kit (Ambion, Inc). The presence of thiouridine modification in the tRNAs was verified by the retardation of electrophoretic mobility in a polyacrylamide gel that contains 0.05 mg/ml (N-acryloylaminophenyl) mercuric chloride (APM) (19,29,40,41). Total RNAs were separated by polyacrylamide gel electrophoresis and blotted onto positively charged membrane (Roche Applied Science). Each tRNA was detected with the specific digoxigenin (DIG)-oligodeoxynucleoside probe at the 3′ termini as detailed elsewhere (40,41). Oligodeoxynucleosides used for DIG-labeled probes were zebrafish mitochondrial tRNAGlu, tRNAGln, tRNALys, tRNATrp, tRNALeu(UUR), tRNAAla and 5S rRNA as detailed elsewhere (Supplemental Table S1) (42,43). The oligodeoxynucleotides were generated by using DIG-oligonucleotide Tailing kit (Roche). APM gel electrophoresis, the hybridization and the quantification of 2-thiouridine modification in tRNAs were conducted as detailed (19,29,40,41).

For tRNA Northern blot analysis, 5 μg of total RNAs were electrophoresed through a 10% polyacrylamide gel without (native gel) or with (denature gel) 8 M urea in Tris–borate–EDTA buffer (TBE) (after heating the sample at 65°C for 10 min), and then electroblotted onto a positively charged nylon membrane for the hybridization analysis with DIG-labeled oligodeoxynucleotide probes. Oligodeoxynucleoside probes for mitochondrial tRNAGlu, tRNAGln, tRNALys, tRNATrp, tRNALeu(UUR), tRNAAla and 5S rRNA were described as above. The hybridization and quantification of density in each band were performed as detailed previously (7,44–46).

For tRNA aminoacylation analysis, 5 μg of total RNA were electrophoresed at 4°C through an acid (pH 5.2) 10% polyacrylamide/8 M urea gel to separate the charged and uncharged tRNA as detailed elsewhere (46,47). The gels were electroblotted onto a positively charged nylon membrane (Roche) for the hybridization analysis with oligodeoxynucleotide probes specific tRNALys, tRNATrp, tRNALeu(UUR), tRNATyr, tRNAMet and tRNAAla, as detailed elsewhere (42). Quantification of density in each band was performed as detailed previously (46,47).

The S1 nuclease cleavage analysis was performed as detailed elsewhere (48). In brief, 2 μg of total RNAs were used for the cleavage reaction in the presence of 1 μg/μl total yeast tRNA and 1U/μl S1 nuclease (Thermofisher) in the 5 μl reaction buffer containing 40 mM sodium acetate (pH 4.5), 300 mM NaCl and 2 mM ZnSO4. Reaction mixtures were incubated at 28°C for indicated times and quenched by adding 5 μl loading buffer. Samples were electrophoresed through a 10% denaturing polyacrylamide gel with 8 M urea and then electroblotted onto a positively charged nylon membrane for hybridization analysis with 3′end DIG-labeled oligodeoxynucleotide probes as described above.

Western blotting analysis

Western blotting analysis was performed as detailed elsewhere (42,44,49). Fish were sacrificed after anesthesia and homogenized in RIPA reagent (Invitrogen) using a homogenizer. Twenty micrograms of total cellular proteins were electrophoresed through 10% bis-Tris SDS-polyacrylamide gels and then transferred to a polyvinyl difluoride (PVDF) membrane. The antibodies used include anti-Gtpbp3 (Sigma, HPA042158), anti-Nd5 (Abcam, ab92624), anti-Nd6 (Abcam, ab81212), anti-Cytb (ABclonal, A9762), anti-Co2 (Proteintech, 55070-1-AP), anti-Sdha (Proteintech, 14865-1-AP), anti-Atp5c (Proteintech 60284-1-Ig), anti-Tfam (Proteintech, 19998-1-AP), and anti-Tufm (Proteintech, 26730-1-AP), anti-Yars2 (Abcam, ab228957), anti-Kars (Proteintech, 14951-1-AP), anti-Afg3l2 (Proteintech, 14631-1-AP), anti-Clpp (Proteintech, 15698-1-AP) and anti-Gapdh (Sigma, SAB2701826). Peroxidase AffiniPure goat anti-mouse IgG and goat anti-rabbit IgG (Jackson) were used as secondary antibodies and protein signals were detected using the ECL system (CWBIO). Quantification of density in each band was performed as detailed previously (42).

Quantitative real-time PCR

Quantitative real-time PCR was performed using total RNAs extracted from mutant (MT) and wild type (WT) fish using Totally RNA™ Kit (Ambion) and reverse transcribed with the PrimeScript™ RT Reagent Kit (Takara). FastStart Universal SYBR Green Masters (Roche) were utilized and the 2–ΔΔCt method was used to normalize the genes of interest (Supplementary Table S2) to the endogenous housekeeping gene gapdh.

Blue native electrophoresis analysis

Blue native gel electrophoresis (PAGE) was performed by isolating mitochondrial proteins from MT and WT zebrafish, as detailed previously (50). Samples containing 15 μg of proteins were separated on 3–11% Bis-Tris Native PAGE gel. The primary antibodies applied for this experiment were anti-Ndufa9 (Proteintech, 20312-1-AP), anti-Sdha (Proteintech, 14865-1-AP), anti-Uqcrc2 (Abcam, ab203832), anti-Cox5a (Proteintech, 11448-1-AP), anti-Atp5c (Proteintech 60284-1-Ig) and anti-Vdac1/2(Proteintech, 10866-1-AP). Peroxidase AffiniPure goat anti-mouse IgG and goat anti-rabbit IgG (Jackson) were used as secondary antibodies and protein signals were detected using the ECL system (CWBIO).

Assays of activities of respiratory complexes

The enzymatic activities of Complexes I, II, III, IV and V were assayed as detailed elsewhere (51,52). Briefly, the activity of Complex I was determined through the oxidation of NADH with ubiquinone as the electron acceptor. Complex II was examined through the artificial electron acceptor DCPIP. The activity of Complex III was measured through the reduction of cytochrome c (III) by using d-ubiquinol-2 as the electron donor. The Complex IV was monitored through the oxidation of cytochrome c (II). The activity of complex V was explored through the NADH oxidation via conversion of phosphoenolpyruvate to lactate by two step reactions.

Enzyme histochemistry (EHC) staining for SDH and COX in the frozen-sections were performed as detailed elsewhere (53,54). Briefly, freshly dissected heart tissues were embedded in OCT compound (Tissue-Tek), frozen on dry ice, and sectioned to 10 μm. Tissue sections were then stained by SDH and COX for 15 min and 10 min, respectively.

Whole mount in situ hybridization

Whole mount in situ hybridization was carried out as previously described (55–57). DIG-labeled antisense RNA probes specific to zebrafish cmlc2 were synthesized from linearized pGEM-T Easy Vector, constructed by PCR‐amplifying fragments of the cmlc2 cDNA spanning coding region (GenBank accession number: NM_131329). Zebrafish embryos from various age of post-fertilization were dechorionated in 2 mg/ml pronase in E3 medium and fixed at 4°C in 4% paraformaldehyde in phosphate-buffered saline (PBS) overnight, then transferred to 100% methanol for storage at −20°C overnight before undergoing hybridization. After the hybridization procedure, embryos were washed extensively in PBS with 0.1% Tween 20, re-fixed in 4% paraformaldehyde, and then transferred to 70% glycerol. Stained embryos were visualized using stereoscopic microscopes (SMZ18, Nikon) (42).

Histological studies

For hematoxylin and eosin (H&E) staining, zebrafish was anesthetized, the heart was extracted and fixed in 10% formalin for 24 h at room temperature. Samples were then dehydrated, infiltrated, embedded in paraffin, sliced into 5 μm thick by pathologic microtome (RM2016, Leica). Tissue sections were then stained by hematoxylin and eosin (H&E) as described previously (58).

For wheat germ agglutinin (WGA) (Sigma) immunofluorescent staining, heart tissues were fixed in 4% paraformaldehyde at 4°C overnight, then washed with PBS and incubated in 30% sucrose solution at 4°C overnight. The samples were frozen in OCT compound at −80°C, and 10 μm cryo-sections were cut using a CM1950 cryostat (Leica). Frozen sections were washed in PBS for 10 min before incubated with FITC-conjugated WGA (1:50 in PBS, 1 mg/ml stock solution) for 1 h at room temperature. The nuclei were stained with DAPI (1:1000 in PBS, 10 μM stock solution, Sigma) for 10 mins at room temperature (59). Fluorescence was visualized with a confocal microscope (OLYMPUS, FV1000).

Quantitative assessment of cardiac function

Offspring of the gtpbp3 heterozygous Tg (cmlc2: egfp) were used for evaluation of cardiac function (60). The time-lapse image data analyses were performed as described previously (61,62). 5 dpf living larvae were transferred onto glass slides with drops of methylcellulose, and laid at the same orientation before videos were taken. The ventricles of the embedded larvae were observed under an epifluorescence microscope (SMZ25; Nikon, Tokyo, Japan), and images were recorded at 100 frames/s for 10 s. Time-lapse images, the long and short axis diastolic and systolic diameters of the ventricle were measured using Olympus software CellSense.

Transmission electron microscopy

The ultrastructure of adult zebrafish hearts at 1 year old was observed using transmission electron microscopy. Heart-tissues were fixed in 2.5% glutaraldehyde, embedded in Epon 812, and cut into 100-nm thick slices using UC7 ultramicrotome (Leica, Heerbrugg, Switzerland), then stained with uranyl acetate and lead citrate. Finally, the images of myocardial ultra-structure were captured by a Hitachi-7650 transmission electron microscope (Hitachi, Tokyo, Japan).

Computer analysis

Variance analysis was performed by the analysis of variance (ANOVA) test contained in GraphPad Prism 7 (Graphpad) and entering individual replicate values. Differences were considered significantly at a P < 0.05.

RESULTS

Generation of gtpbp3 knock-out zebrafish using CRISPR/Cas9 system

To investigate the pathological consequences of gtpbp3 mutation, we used the CRISPR/Cas9 technology to generate zebrafish mutant lines where the Gtpbp3 ortholog was disrupted. As shown in Figure 1A, a single guide RNA (sgRNA) targeting exon 2 of gtpbp3 was injected into wild-type one-cell stage embryos together with Cas9 mRNA. As a result, an allele, gtpbp3del14bp was generated by introducing a 14 bp deletion in the exon 2 of gtpbp3 (heterozygous and homozygous zebrafish were described as gtpbp3+/−, gtpbp3−/- and wild type as WT). In fact, this deletion caused a frameshift from codon 55 and the introduction of a premature stop at codon 98 (Figure 1A, B). This allele was subsequently propagated after confirmation of the mutation by Sanger sequencing, DNA-PAGE and Western blot analyses (Figure 1BD). Both gtpbp3+/− and gtpbp3−/− zebrafish were adult-viable. Furthermore, there was no notable difference in gross morphology between mutant and wild type 5 dpf embryos (Figure 1E). The ratios of genotypes of offsprings (F2) in clutches from different F1 gtpbp3 heterozygous crosses mirrored the Mendelian ratio (Figure 1F).

Figure 1.

Figure 1.

Genome editing of gtpbp3 in zebrafish using CRISPR/Cas9 system. (A) Schematic representation of CRISPR/Cas9 target site at exon 2 of zebrafish gtpbp3 gene as used in this study. White boxes indicate coding region, black boxes indicate untranslated regions of exons and lines between exons indicate introns. The resultant truncated 98 aa non-functional protein caused by frame shifting deletion in gtpbp3 is shown in diagram. (BD) Genotyping of gtpbp3del14bp by Sanger sequence, the PAGE and Western blot analyses. (E) Lateral views of gtpbp3+/+, gtpbp3+/−, gtpbp3−/− zebrafish at 5 dpf. (F) The ratios of genotypes/phenotype of offsprings (F2) in clutches from different F1 gtpbp3+/- heterozygous crosses at 10 dpf (n = 42).

Analysis of nucleotide modification and steady-state levels of mitochondrial tRNAs

It was hypothesized that the loss of Gtpbp3 led to a failure in tRNA metabolism (32). To investigate whether the loss of Gtpbp3 affected the nucleotide modification at position 34 of tRNAs in zebrafish, the 2-thiouridylation levels of tRNAs were determined by isolating total RNAs from gtpbp3+/+, gtpbp3+/− and gtpbp3−/− zebrafish, quantifying the 2-thiouridine modification by the retardation of electrophoresis mobility in APM polyacrylamide gel, and hybridizing DIG-labeled probes for mitochondrial tRNAGlu, tRNAGln, tRNALys, tRNATrp, tRNALeu(UUR) and tRNAAla as well as 5S rRNA as internal controls (40–42). In this system, the mercuric compound specifically interacted with the tRNAs containing the thiocarbonyl group, such as tRNAGlu, tRNAGln and tRNALys, thereby retarding tRNA migration. As shown in Figure 2A, 2-thiouridylation levels of mitochondrial tRNAGlu, tRNAGln and tRNALys in gtpbp3+/− and gtpbp3−/− zebrafish were comparable with those in gtpbp3+/+ zebrafish.

Figure 2.

Figure 2.

Northern blotting analysis of mitochondrial tRNAs. (A) APM gel electrophoresis. Five μg of mutant and WT zebrafish total RNAs were separated by polyacrylamide gel electrophoresis that contains 0.05 mg/ml APM, electroblotted onto a positively charged membrane, and hybridized with DIG-labeled oligonucleotide probes specific for tRNAGlu, tRNAGln, tRNALys, tRNATrp, tRNALeu(UUR), tRNAAla and 5S rRNA, respectively. The retarded bands of 2-thiolated tRNAs and non-retarded bands of tRNA without thiolation are marked by arrows. (B) Northern blot analysis of tRNA under a denaturing condition. Five μg of mutant and WT zebrafish total RNAs were electrophoresed through a denaturing polyacrylamide gel, electroblotted and hybridized with the same DIG-labeled oligonucleotide probes as described above.

To assess if the gtpbp3 mutation altered the stability of tRNAs, we subjected total RNAs from mutant and WT zebrafish to Northern blotting and hybridized them with DIG-labeled oligodeoxynucleotide probes tRNAGlu, tRNAGln, tRNALys, tRNATrp, tRNALeu(UUR), tRNAAla and 5S rRNA, respectively (Figure 2B). For comparison, the levels of each tRNA were normalized to the reference 5S rRNA. The steady-state levels of tRNALys was mildly reduced in gtpbp3−/− zebrafish, but the levels of tRNAGlu, tRNAGln, tRNATrp, tRNALeu(UUR) and tRNAAla from gtpbp3 mutant zebrafish were all comparable with those in WT zebrafish.

Altered conformation of mitochondrial tRNAs

Modifications of tRNA participate in forming the structure of a certain tRNA (63–64). It is anticipated that the deficient nucleotide modification may affect the conformation of mitochondrial tRNA. To test this hypothesis, total RNAs were electrophoresed through 10% polyacrylamide gel (native condition) in Tris-glycine buffer and then electroblotted onto a positively charged nylon membrane for hybridization analysis with DIG-labeled oligodeoxynucleotide probes for tRNAGlu, tRNALys, tRNATrp, tRNALeu(UUR) with taurine modification and tRNAAla without taurine modification (14), respectively. As shown in Figure 3A, electrophoretic patterns under native condition showed that the tRNAGlu, tRNALys, tRNATrp in gtpbp3−/− zebrafish migrated faster than those of WT zebrafish, while tRNALeu(UUR) in gtpbp3−/− zebrafish migrated slightly slower than those in WT zebrafish. However, there were no obvious electrophoretic mobility differences of the tRNAAla between gtpbp3−/− and WT zebrafish.

Figure 3.

Figure 3.

Analysis of mitochondrial tRNA conformation. (A) Northern blot analysis of tRNAs under native condition. Five μg of mutant and WT zebrafish total RNAs were electrophoresed through a native polyacrylamide gel, electroblotted and hybridized with the same DIG-labeled oligonucleotide probes as tRNAGlu, tRNATrp, tRNALeu(UUR), tRNALys and tRNAAla, respectively. (B) S1 digestion patterns of tRNAGlu, tRNATrp, tRNALeu(UUR), tRNALys and tRNAVal, purified from gtpbp3−/− and WT zebrafish. Two micrograms of RNAs were used for the S1 cleavage reaction at various lengths (from 0 to 120 min). Cleavage products of tRNAs were resolved in 10% denaturating PAGE gels with 8 M urea, electroblotted and hybridized with 3′ end DIG-labeled oligonucleotide probes specific for tRNAGlu, tRNATrp, tRNALeu(UUR), tRNALys and tRNAVal, respectively. Arrows denoted the 30 to 40 nt regions showing 3′ tRNA half.

We further evaluated whether the loss of Gtpbp3 perturbed the structures of tRNAs by analyzing the sensitivity of tRNAGlu, tRNALys, tRNATrp and tRNALeu(UUR) (present taurine modification in WT) as well as tRNAVal (absent taurine in WT), from gtpbp3−/− and WT zebrafish to digestion with the nuclease S1. The resultantly digested-products from gtpbp3−/− and WT zebrafish were then followed by Northern blot analysis using tRNA probes that hybridized only to 3′ half tRNAs. As illustrated in Figure 3B, the tRNAGlu, tRNALys, tRNATrp and tRNALeu(UUR) from gtpbp3−/− zebrafish were more sensitive to S1-mediated digestion than those from WT zebrafish and exhibited remarkable differences in S1-mediated digestion patterns of tRNAs from gtpbp3−/− zebrafish. Notably, tRNAGlu was the most sensitive to S1 digestion, even the tRNA half of tRNAGlu was already present only in gtpbp3−/− zebrafish. The sensitive tRNAGlu from gtpbp3−/− zebrafish to S1-mediated digestion was correlated with the drastic changes of electrophoretic mobility. Furthermore, the nuclease S1 degraded full-length tRNALys, tRNALeu(UUR) and tRNATrp faster in gtpbp3−/− zebrafish than those in WT. As shown in Supplemental Figure S3, the ratios of tRNA half/full length tRNAGlu, tRNALys and tRNALeu(UUR) did not differ significantly between gtpbp3−/− and WT zebrafish, respectively, whereas the ratio of tRNA half/full-length tRNATrp in gtpbp3−/− zebrafish increased significantly more than those in WT zebrafish during the digestion time. Conversely, there was no significant difference between the sensitivity of tRNAVal from gtpbp3−/− and WT zebrafish to digestion with the nuclease S1. These data validated that the inactivation of Gtpbp3 changed the conformation of mitochondrial tRNAs.

Increased aminoacylation of mitochondrial tRNAs

To assess whether the loss of Gtpbp3 affected the aminoacylation of tRNA, we examined the aminoacylation levels of tRNALys, tRNALeu(UUR), tRNATrp, tRNATyr, tRNAAla and tRNAMet by using electrophoresis in an acidic urea PAGE system to separate uncharged tRNA species from the corresponding charged tRNA, electroblotting and hybridizing with the tRNA probes described above. As shown in Figure 4A, the tRNALys, tRNALeu(UUR) and tRNATrp in the gtpbp3−/− zebrafish migrated slightly faster than those of WT zebrafish, while there were no obvious differences in electrophoretic mobility of tRNATyr, tRNAAla and tRNAMet between gtpbp3−/− and WT zebrafish. Notably, gtpbp3−/− and gtpbp3+/- zebrafish exhibited marked increases in the aminoacylated levels of mitochondrial tRNAs, as compared with those in WT zebrafish. As shown in Figure 4B and Table 1, the efficiencies of aminoacylated tRNALys, tRNALeu(UUR), tRNATrp, tRNATyr, tRNAAla and tRNAMet in the gtpbp3−/− zebrafish were 168%, 167%, 146%, 140%, 295% and 132% of those in WT zebrafish, the efficiencies of aminoacylated tRNALys, tRNALeu(UUR), tRNATrp, tRNATyr, tRNAAla and tRNAMet in the gtpbp3+/− zebrafish were 140%, 168%, 131%, 121%, 252% and 127% of those in WT zebrafish.

Figure 4.

Figure 4.

In vivo aminoacylation assays. (A) Five μg of gtpbp3+/− and gtpbp3−/− and WT zebrafish total RNAs under acid conditions were electrophoresed at 4°C through an acid (pH 5.2) 10% polyacrylamide with 8 M urea gel, electroblotted, and hybridized with a DIG-labeled oligonucleotide probes specific for the tRNATrp, tRNALys, tRNALeu(UUR), tRNATyr, tRNAAla and tRNAMet, respectively. (B) Quantification of aminoacylated proportions of tRNAs in mutant and WT zebrafish. The calculations were based on three independent experiments. The error bars indicate two standard deviations (SD) of the means. P indicates the significance, according to ANOVA test, of the difference between gtpbp3+/− or gtpbp3−/− and WT values for proteins, denoted by asterisks (*P< 0.05, **P< 0.01, ***P< 0.001), and non-significant differences by n.s.

Table 1.

Quantification of the levels of aminoacylated mitochondrial tRNAs (%)

tRNALys tRNATrp tRNALeu(UUR) tRNATyr tRNAMet tRNAAla
gtpbp3 +/+ 45 ± 5 58 ± 3 27 ± 2 48 ± 2 54 ± 5 16 ± 1
gtpbp3 +/− 64 ± 4 76 ± 5 46 ± 3 58 ± 2 68 ± 8 39 ± 2
gtpbp3 −/− 76 ± 2 85 ± 7 45 ± 4 67 ± 7 71 ± 4 46 ± 1

The average levels of aminoacylated mitochondrial tRNALys, tRNATrp, tRNALeu(UUR), tRNATyr, tRNAMet and tRNAAlawere based on three independent determinations of each tRNA in mutant and wild type zebrafish. The values were expressed as percentages of the average values for the aminoacylated mitochondrial tRNA.

Reductions in the levels of mitochondrial proteins

To investigate whether the aberrant mitochondrial tRNA metabolism altered mitochondrial translation, Western blotting analysis was carried out to examine the subunits of OXPHOS, including four mtDNA encoding polypeptides (Nd5, Nd6, Cytb and Co2), two nuclear encoding proteins Atp5c and Sdha and four mitochondrial proteins: non-OXPHOS subunits (Kars, Yars2, Tufm and Tfam) in mutant and WT zebrafish using Gapdh as a loading control. As shown in Figure 5A, the levels of Nd5, Nd6 (subunits 5 and 6 of NADH dehydrogenase), Cytb (subunit of ubiquinol-cytochrome c reductase), Co2 (subunit II of cytochrome c oxidase), Sdha (subunit of succinate dehydrogenase), Atp5c (subunit of H+-ATPase), Tfam (transcription factor A, mitochondrial), Mto1 (mitochondrial tRNA translation optimization 1), Trmu (tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase), Tufm (Tu translation elongation factor, mitochondrial), Kars (lysyl-tRNA synthetase) and Yars2 (tyrosyl-tRNA synthetase 2) were decreased in mutant zebrafish, as compared with those in WT zebrafish. Notably, the levels of Nd5, Nd6, Cytb and Co2 in gtpbp3−/− zebrafish were 5%, 27%, 4% and 43%, with the average of 18%, relative to the mean values measured in the WT zebrafish (P < 0.0001). Furthermore, the average levels of these mtDNA-encoding proteins in gtpbp3+/− zebrafish were 36%, relative to the average values in WT zebrafish. Moreover, the levels of Atp5a and Sdha in the gtpbp3−/− zebrafish were 46% and 22% of the average values measured in the WT zebrafish (Figure 5B). As showed in Figure 5D, the levels of Tfam, Mto1, Trmu, Tufm, Kars and Yars2 in gtpbp3−/− zebrafish were 34%, 48%, 58%, 47%, 10% and 37%, relative to the mean value measured in WT zebrafish (P < 0.05).

Figure 5.

Figure 5.

Western blotting analysis of mitochondrial proteins. (A, C) Twenty micrograms of total proteins from mutant and WT zebrafish at the age of one year were electrophoresed through a denaturing polyacrylamide gel, electroblotted and hybridized with antibodies for 6 subunits of OXPHOS (four encoded by mtDNA and two encoded by nuclear genes), Tfam, Mto1, Trmu, Kars, Yars2, Tufm as well as Gapdh as a loading control. Quantification of levels of OXPHOS subunits (B) and other mitochondrial proteins (D). Average content of Nd5, Nd6, Cytb, Co2, Atp5c, Sdha, Tfam, Mto1, Trmu, Kars, Yars2 and Tufm was normalized to the average content of Gapdh in mutant and wild type zebrafish. The horizontal dashed lines represent the average values of four proteins encoded by mtDNA or two proteins encoded by nuclear genes for each group (B). The calculations were based on three independent determinations. Graph details and symbols are explained in the legend to Figure 4.

Imbalances in protein stoichiometry of OXPHOS complexes

To determine if these decreased nuclear-encoding proteins resulted from transcriptional downregulation, we performed the real-time PCR analysis of sdha, atp5c, tfam, mto1, trmu, tufm, kars and yars2. As shown in Supplemental Figure S4, no significant differences in the levels of these eight genes were observed among the MT and WT zebrafish.

To test whether the Gtpbp3-defiency affected the mitochondrial proteostasis, we measured the levels of Clpp involved in mitochondrial ribosome assembly (65) and ATP family gene 3-like2 (Afg3l2) proteases involved in the turnover of misfolded proteins markers for proteostasis stress (66), in the MT and WT zebrafish. As shown in Figure 6A,B, the levels of Afg3l2 and Clpp in gtpbp3−/− zebrafish were 157% and 195%, and the levels of Afg3l2 and Clpp in gtpbp3+/− zebrafish were 132% and 157%, relative to the mean values measured in the WT zebrafish, respectively. These data indicated that gtpbp3 mutation produced the proteostasis stress.

Figure 6.

Figure 6.

Imbalances in protein stoichiometry of OXPHOS complexes. (A) Western blotting analysis of Afg3l2 and Clpp proteins. Twenty micrograms of total cellular proteins from mutant and WT zebrafish were electrophoresed through a denaturing polyacrylamide gel, electroblotted and hybridized with antibodies for Afg3l2 and Clpp as well as Gapdh as a loading control. (B) Quantification of levels of Afg3l2 and Clpp. The calculations were based on three independent experiments. (C) The steady-state levels of five OXPHOS complexes by Blue-Native gel electrophoresis. Fifteen μg of mitochondrial proteins from mutant and WT zebrafish were electrophoresed through a Blue-Native gel, electroblotted and hybridized with antibodies for Ndufa9, Sdha, Uqcrc2, Cox5a, Atp5c (subunits of complex I, II, III, IV and V, respectively) as well as Vdac as a loading control. (D) Quantification of levels of complexes I, II, III, IV and V in mutant and WT zebrafish. The calculations were based on three independent experiments. Graph details and symbols are explained in the legend to Figure 4.

To investigate whether the gtpbp3 mutation-induced alterations affected the stability of OXPHOS complexes, we measured the steady-state levels of five OXPHOS complexes by Blue-Native gel electrophoresis. As shown in Figure 6C,D, the levels of complex I (C I), complex II (C II) and complex IV (C IV) in gtpbp3−/− zebrafish were 9%, 50% and 63% of the mean values measured in the WT zebrafish, respectively. Similarly, the levels of C I, C II and C IV in gtpbp3+/− zebrafish were 20%, 57% and 63%, relative to the mean values measured in WT zebrafish. However, the levels of C III and C V in gtpbp3−/- and gtpbp3+/− were comparable with those in WT zebrafish. The lower levels of the respiratory complexes I, II and IV may be due to the misfolded and/or misassembled.

Reduced activities of respiratory complexes

To examine the effect of gtpbp3 mutation on the oxidative phosphorylation, we measured the activities of respiratory complexes by isolating mitochondria from gtpbp3+/+, gtpbp3+/− and gtpbp3−/− zebrafish. Complex I activity was determined by following the oxidation of NADH with ubiquinone as the electron acceptor (51,52). The activity of complex II (succinate ubiquinone oxidoreductase), which was exclusively encoded by the nuclear DNA, was examined by the artificial electron acceptor DCPIP. Complex III (ubiquinone cytochrome c oxidoreductase) activity was measured as the reduction of cytochrome c (III) using d-ubiquinol-2 as the electron donor. Complex IV (cytochrome c oxidase) activity was monitored by following the oxidation of cytochrome c (II). Complex V (F1, F0-ATP synthetase) activity was measured as the oxidation of NADH using phosphoenolpyruvate as the electron acceptor (51,67,68). As shown in Figure 7, the activities of Complex I, II, III, IV and V in gtpbp3−/− zebrafish were 36.5%, 67.5%, 82.7%, 37.8% and 78.3%, relative to the mean values measured in the WT zebrafish, respectively. Furthermore, the activities of Complex I, II, III, IV and V in gtpbp3+/- zebrafish were 60.4%, 77.4%, 89.4%, 52.8% and 79.2% of the average values measured in WT zebrafish, respectively.

Figure 7.

Figure 7.

Enzymatic activities of respiratory chain complexes. The activities of respiratory complexes were investigated by enzymatic assays on complexes I, II, III, IV and V in mitochondria isolated from mutant and wild type zebrafish at the ages of one year. The calculations were based on three independent determinations. Graph details and symbols are explained in the legend to Figure 4.

Loss of Gtpbp3 altered embryonic heart development

Heart was the first organ to form and function during zebrafish embryonic development (69–71). As shown in Figure 8A, cardiac primordium went through migration and left-jogging process within the first day post fertilization and initiated contraction around 1 dpf. The chambers of ventricle and atrium formed and the whole heart underwent an S-looping process at 2 dpf. Finally, the functional heart was formed at 5 dpf (72,73). Cardiac-specific marker cmlc2 was used to investigate the effect of gtpbp3 deletion on heart development by either green fluorescence or whole-mount in situ hybridization at 2 dpf. As shown in Figure 8B, gtpbp3ko zebrafish exhibited various degrees of perturbed S-looping processing. Based on looping angles between ventricle and atrium, zebrafish hearts were divided into categories of normal (α<90°), mild (90° < α < 180°), and severe (α>180°) (Figure 8C). As shown in Figure 8D, 19% gtpbp3+/+ (n = 42), 28% gtpbp3+/− (n = 46) and 24% gtpbp3−/– (n = 41) displayed mild-loop heart, respectively. In contrast, 2% gtpbp3+/+ (n = 42), 4% gtpbp3+/− (n = 46) and 20% gtpbp3−/– (n = 41) had no-loop heart, respectively. These data indicated that the deletion of gtpbp3 led to defects in embryonic heart development.

Figure 8.

Figure 8.

Cardiac defects in zebrafish. (A) Schematic diagram of zebrafish heart development at 1, 2 and 5 dpf. V, ventricle; A, atrium. (B) Tg (cmlc2:egfp) embryos at 2 dpf shows heart-restricted GFP expression in both chambers. (C) Whole-mount in situ hybridization against cmlc2. According to the looping state, measured by the angles between ventricle and atrium, hearts were divided into normal (α<90°), mild (90°<α<180°), and severe (α > 180°). (D) The proportions of each phenotypes in the embryos in mutant and WT zebrafish. (E) Time-lapse images, the ventricular long axis and ventricular short axis were labeled as VL and VS, respectively. End diastolic (red line) and systolic (green line) diameters of zebrafish ventricle at 5 dpf were measured using Olympus software CellSense. (F) The proportions of the short axis fractional shortening (FSS), long axis fractional shortening (FSL) and fractional area change (FAC) in mutant and WT zebrafish. the calculations were based on eight independent determinations. Graph details and symbols are explained in the legend to Figure 4.

We then evaluated if the loss of Gtpbp3 altered the heart function of zebrafish at 5dpf by time-lapse images. This technique allowed us to examine the extent of ventricle during the process of diastole and systole. As illustrated in Figure 8E, ventricular functions were evaluated by measuring the fractional shortening level of short axis (FSS), fractional shortening level of long axis (FSL) and fractional area change (FAC) of ventricle. As shown 8F, FSS, FSL and FAC of gtpbp3+/- zebrafish were 78% (P = 0.0153), 95% (P = 0.6856) and 91% (P = 0.3386) of the mean values measured in WT zebrafish, respectively, while FSS, FSL and FAC of gtpbp3−/- zebrafish were 71% (P = 0.0038), 67% (P = 0.0039) and 71% (P = 0.0056) of the mean values measured in WT zebrafish, respectively. These results demonstrated that the deletion of gtpbp3 altered cardiac function.

The gtpbp3 mutants exhibited hypertrophic cardiomyopathy in adult zebrafish.

We then investigated if the gtpbp3ko zebrafish recapitulated the hypertrophic cardiomyopathy phenotypes in patients carrying the GTPBP3 mutations. As shown in Figure 9A, cardiomyocytes of one-year-old gtpbp3−/− zebrafish stained with hematoxylin/eosin (H&E) showed hypertrophy of cardiac myocytes and myocardial fiber disarray. The abnormal myocytes included the enlarged size, bizarre-shaped nuclei and disorganized patterns. Furthermore, the volumes of the interstitial matrix were increased in the gtpbp3−/− zebrafish. As shown in Figure 9B, the cross-sectional areas of cardiomyocytes in gtpbp3−/− and gtpbp3+/- zebrafish were 156% (P = 0.0007) and 124% (P = 0.0546) relative to the mean values measured in WT zebrafish. As illustrated in Figure 9C, D, these phenotypes were verified by direct staining the outline of cardiomyocyte by FITC-conjugated WGA and marked increasing expression of nppa and nppb genes (HCM marker) in gtpbp3−/− and gtpbp3+/- zebrafish (74–76). As shown in Figure 9E, the gtpbp3+/− and gtpbp3−/− zebrafish exhibited defects in cardiac myofibrils and widened I-bands using transmission electron micrographs. As shown in Figure 9F, the lengths of I-bands were significantly increased in gtpbp3−/− and gtpbp3+/−zebrafish, as compared with those in WT zebrafish. These data demonstrated that gtpbp3−/−zebrafish recapitulated the clinical phenotypes in HCM patients carrying the GTPBP3 mutations.

Figure 9.

Figure 9.

Hypertrophic cardiomyopathy in zebrafish. (A) Hematoxylin and eosin stained (H&E) histological sections of hearts from gtpbp3−/−, gtpbp3+/− and gtpbp3+/+ zebrafish at the age of one year. Scale bars: 10 μm. (B) The relative cross-sectional area of cardiomyocyte in gtpbp3+/+ (n = 136), gtpbp3+/- (n = 147), gtpbp3−/− (n = 116) zebrafish, staining with H&E. (C) The cardiomyocytes from mutant and WT zebrafish were visualized via WGA staining. Scale bars: 5 μm. (D) Relative levels of nppa and nppb gene in hearts from mutant and WT zebrafish. (E) Ventricular heart muscle sections of transmission electron microscopy in mutant and WT zebrafish. Ultrathin sections were visualized with 15,000X magnifications. Altered myofibrils were indicated by white arrows and widened I-band in the sarcomere units were indicated by white arrowhead. Scale bars: 1 μm. (F) Quantification of the I-band length of gtpbp3+/+ (n = 16), gtpbp3+/- (n = 38) and gtpbp3−/− (n = 37) zebrafish. The values for the mutants were expressed as percentages of the average values for the wild type.

Mitochondrial defects in cardiomyocytes

Mitochondrial dysfunction in cardiomyocytes was assessed by enzyme histochemistry staining for SDH and COX in the frozen-sections of ventricles of gtpbp3−/−, gtpbp3+/-and WT zebrafish at one year old. As shown in Figure 10A and B, mildly reduced activity of COX, but significantly increased activity of SDH were observed in gtpbp3−/− zebrafish, as compared to the wild type zebrafish. Mitochondrial defects in cardiomyocytes of mutant and WT zebrafish at one year old were further evaluated by using transmission electron microscope. As shown in Figure 10C, cardiomyocytes of gtpbp3−/− mutant zebrafish exhibited abnormal mitochondrial morphology including enlarged mitochondria and the partial loss of cristae, as compared to those of wild type zebrafish. Especially, mitochondrial volumes in gtpbp3−/− (n = 92) and gtpbp3+/− (n = 65) mutant cells were 176% and 172%, related to the average values of control cells (n = 147). The huge volume mitochondria were probably due to compensation for mitochondrial dysfunction.

Figure 10.

Figure 10.

Mitochondrial defects in the zebrafish heart. (A, B) Assessment of mitochondrial function in cardiomyocytes by enzyme histochemistry (EHC) staining for COX (A) and SDH (B) in the frozen-sections of ventricles in the gtbpbp3−/−, gtpbp3+/− and gtpbp3+/+ zebrafish at one year old. Scale bars: 40 μm. (C) Mitochondrial networks from cardiomyocytes of transmission electron microscopy. Ultrathin sections were visualized with 30 000× magnifications.

DISCUSSION

In the present study, we investigated the impacts of Gtpbp3 in mitochondrial biogenesis and cardiac function by characterizing gtpbp3 knockout zebrafish generated using CRISPR/Cas9 system. Gtpbp3 is a highly conserved tRNA modifying enzyme responsible for the biogenesis of τm5U at the wobble position of mitochondrial tRNAGlu, tRNAGln, tRNALys, tRNATrp and tRNALeu(UUR) (11,14,22,36,40,77,78). These were further evidenced by the complete loss of τm5U at the wobble position of mitochondrial tRNAGlu, tRNAGln, tRNALys, tRNATrp and tRNALeu(UUR) in the human GTPBP3 KO cells (14). It was hypothesized that the gtpbp3 deletion resulted in the aberrant structure and function of tRNAs including the stability, functional folding and aminoacylation. However, the inactivation of gtpbp3 did not affect the 2-thiouridylated levels at U34 of tRNALys, tRNAGlu and tRNAGln in zebrafish, in contrast with the complete loss of τm5s2U at U34 of tRNALys, tRNAGlu and tRNAGln in Trmu-KO zebrafish (42). These data further supported that the thiolation at position 2 was independent of the modification at position 5 (14,79). Furthermore, the loss of Gtpbp3 caused only mildly reduced level of tRNALys but did not change the levels of other five tRNAs in the gtpbp3−/− zebrafish. The inactivation of Gtpbp3 led to different effects of tRNAGlu, tRNALys, tRNATrp and tRNALeu(UUR) on the tertiary structure including functional folding of tRNAs. These were evidenced by various electrophoretic mobility changes and sensitivity to S1-mediated digestion of these tRNA in the gtpbp3−/− zebrafish, as compared with those in WT zebrafish. These different effects are likely due to the different types of modifications at U34 in mitochondrial tRNAGlu, tRNAGln, tRNALys, tRNATrp and tRNALeu(UUR), even though these tRNAs shared identical taurine modification at U34 (4, 14). Strikingly, the loss of Gtbpb3 indeed increased the aminoacylated levels of tRNALys, tRNATrp, tRNALeu(UUR), tRNATyr, tRNAMet and tRNAAla in the mutant zebrafish. The elevated levels of aminoacylated tRNAs in mutant zebrafish may be due to some levels of stabilization by compensatory effects (18,44,80). Alternatively, the unmodified U34 of these tRNAs may lead to mitochondrial ribosome pausing at their cognate codon and make the accumulation of aminoacylated tRNAs (81). Moreover, the increasing aminoacylated levels of these tRNAs may also result from the elevation of misacylated tRNAs caused by defective nucleotide modifications (82). The deficient modifications at wobble position of tRNAs caused by the gtpbp3 deletion may affect the fidelity and efficiency of mitochondrial translation. In fact, the loss of τm5U modification may destabilize the U:G wobble base-pairing by increasing stacking interactions and affect the decoding accuracy through altered codon-anticodon interactions (6,23,83,84). Alternatively, the deficient τm5U modifications caused the inefficiency of mitochondrial translation (82,85,86). In the present study, 66% and 82% decreases in the average levels of 4 mtDNA encoding proteins were observed in the gtpbp3+/− and gtpbp3−/− mutant zebrafish, respectively. These results were consistent with the reduced rates of mitochondrial translation observed in human cell lines carrying the GTPBP3 mutations or depletions (32,35).

The mitochondrial translational defects led to the imbalances between the increased levels of de novo protein synthesis and decreased folding capacity for the mtDNA- and nucleus-encoded mitochondrial proteins (87). Hence, the gtpbp3 mutation-induced translational defects may lead to a buildup of unfolded and/or unassembled subunits of OXPHOS, thereby reducing the steady-state levels of OXPHOS complexes. The aberrant mitochondrial translation produced the proteostasis stress, such as increased protein degradation or misfolding in mitochondria, was evidenced by the increased levels of Afg3l2 and Clpp in gtpbp3−/- and gtpbp3+/− zebrafish (65,66). As a result, these alterations resulted in various reductions in nuclear encoding mitochondrial proteins:Atp5c, Sdha, Tfam, Mto1, Trmu, Tufm, Kars and Yars2. The defective mitochondrial translations resulted in the defective activities of complex I, II, III, IV and V, deficient ATP synthesis, and subsequent failure of cellular energetic process (88,89). These mitochondrial dysfunctions were further verified by the altered activities of SDH and COX and abnormal mitochondrial morphology in the cardiomyocytes of gtpbp3−/− mutant zebrafish. These data demonstrated that the gtpbp3 knock-out zebrafish recapitulated the biochemical phenotypes in human cell lines carrying the mutations and knockdown of GTPBP3 gene (14,32,35,90).

The heart is the most energy-demanding organ in vertebrate body. Therefore, we hypothesized that mitochondrial dysfunction caused by Gtpbp3-deficieny particularly ablated the heart function. In zebrafish, cardiac primordium went through migration and left-jogging process around 1 dpf, the chambers of ventricle, and atrium formed and the whole heart underwent an S-looping process at 2 dpf and the functional heart was formed at 5 dpf (73–75). In this study, the gtpbp3−/− mutant larvae at 2 dpf revealed the abnormal S-loops in heart, indicating that the loss of Gtpbp3 altered the embryonic heart development. The cardiac defects were further evidenced by the fact that the gtpbp3−/− mutant zebrafish exhibited the reduced fractional shortening of ventricles at 5dpf. Furthermore, gtpbp3−/− adult zebrafish displayed the hypertrophy of cardiac myocytes and myocardial fiber disarray in ventricles. These cardiac defects in gtpbp3−/-zebrafish recapitulated the clinical phenotypes in HCM patients carrying the GTPBP3 mutations (32,91–93). These data demonstrated that the gtpbp3-deletion-induced mitochondrial dysfunctions caused hypertrophic cardiomyopathy. Thus, our findings may provide new insights into the pathophysiology of hypertrophic cardiomyopathy, which was manifested by the aberrant nucleotide modification of mitochondrial tRNAs.

In summary, our findings demonstrated the pathophysiology of hypertrophic cardiomyopathy underlying GTPBP3 deficiency using the gtpbp3 knock-out zebrafish. The deficient modifications caused by the deletion of Gtpbp3 perturbed the tertiary structures and function of mitochondrial tRNA. The aberrant mitochondrial tRNA metabolisms produced the impairment of mitochondrial translation, proteostasis, instability of OXPHOS, respiratory phenotypes and decreased ATP production. These mitochondria dysfunctions caused the alterations in the embryonic heart development, the reduced fractional shortening of ventricles, hypertrophy of cardiac myocytes and myocardial fiber disarray in ventricles. These cardiac defects in gtpbp3−/-zebrafish recapitulated the clinical phenotypes in HCM patients carrying the GTPBP3 mutations. Our findings highlight the fundamental role of aberrant nucleotide modifications of mitochondrial tRNAs in mitochondrial biogenesis and their pathological consequences in hypertrophic cardiomyopathy.

Supplementary Material

gkz218_Supplemental_Files

ACKNOWLEDGEMENTS

We thank Drs Jun Chen, Pengfei Xu and Peidong Han for their constructive suggestions.

SUPPLEMENTARY DATA

Supplementary Data are available at NAR Online.

FUNDING

National Basic Research Priorities Program of China [2014CB541704 to M.X.G.]; National Natural Science Foundation of China [81330024 to M.X.G.]. Funding for open access charge: National Basic Research Priorities Program of China [2014CB541704]; National Natural Science Foundation of China [81330024].

Conflict of interest statement. None declared.

REFERENCES

  • 1. Cantara W.A., Crain P.F., Rozenski J., McCloskey J.A., Harris K.A., Zhang X., Vendeix F.A., Fabris D., Agris P.F.. The RNA modification Database, RNAMDB: 2011 update. Nucleic Acids Res. 2011; 39:D195–D201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Boccaletto P., Machnicka M.A., Purta E., Piatkowski P., Baginski B., Wirecki T.K., de Crecy-Lagard V., Ross R., Limbach P.A., Kotter A. et al.. MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 2018; 46:D303–D307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Armengod M.E., Meseguer S., Villarroya M., Prado S., Moukadiri I., Ruiz-Partida R., Garzon M.J., Navarro-Gonzalez C., Martinez-Zamora A.. Modification of the wobble uridine in bacterial and mitochondrial tRNAs reading NNA/NNG triplets of 2-codon boxes. RNA Biol. 2014; 11:1495–1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Suzuki T., Suzuki T.. A complete landscape of post-transcriptional modifications in mammalian mitochondrial tRNAs. Nucleic Acids Res. 2014; 42:7346–7357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Agris P.F., Vendeix F.A., Graham W.D.. tRNA’s wobble decoding of the genome: 40 years of modification. J. Mol. Biol. 2007; 366:1–13. [DOI] [PubMed] [Google Scholar]
  • 6. Tukenmez H., Xu H., Esberg A., Bystrom A.S.. The role of wobble uridine modifications in +1 translational frameshifting in eukaryotes. Nucleic Acids Res. 2015; 43:9489–9499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Wang M., Liu H., Zheng J., Chen B., Zhou M., Fan W., Wang H., Liang X., Zhou X., Eriani G. et al.. A deafness- and diabetes-associated tRNA mutation causes deficient pseudouridinylation at position 55 in tRNAGlu and mitochondrial dysfunction. J. Biol. Chem. 2016; 291:21029–21041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Wang M., Peng Y., Zheng J., Zheng B., Jin X., Liu H., Wang Y., Tang X., Huang T., Jiang P. et al.. A deafness-associated tRNAAsp mutation alters the m1G37 modification, aminoacylation and stability of tRNAAsp and mitochondrial function. Nucleic Acids Res. 2016; 44:10974–10985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Agris P.F. The importance of being modified: Roles of modified nucleosides and Mg2+ in RNA structure and function. Prog. Nucleic Acid Res. Mol. Biol. 1996; 53:79–129. [DOI] [PubMed] [Google Scholar]
  • 10. Jonkhout N., Tran J., Smith M.A., Schonrock N., Mattick J.S., Novoa E.M.. The RNA modification landscape in human disease. RNA. 2017; 23:1754–1769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Moukadiri I., Prado S., Piera J., Velazquez-Campoy A., Bjork G.R., Armengod M.E.. Evolutionarily conserved proteins MnmE and GidA catalyze the formation of two methyluridine derivatives at tRNA wobble positions. Nucleic Acids Res. 2009; 37:7177–7193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Armengod M.E., Moukadiri I., Prado S., Ruiz-Partida R., Benitez-Paez A., Villarroya M., Lomas R., Garzon M.J., Martinez-Zamora A., Meseguer S. et al.. Enzymology of tRNA modification in the bacterial MnmEG pathway. Biochimie. 2012; 94:1510–1520. [DOI] [PubMed] [Google Scholar]
  • 13. Suzuki T., Suzuki T., Wada T., Saigo K., Watanabe K.. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J. 2002; 21:6581–6589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Asano K., Suzuki T., Saito A., Wei F.Y., Ikeuchi Y., Numata T., Tanaka R., Yamane Y., Yamamoto T., Goto T. et al.. Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease. Nucleic Acids Res. 2018; 46:1565–1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Nakano S., Suzuki T., Kawarada L., Iwata H., Asano K., Suzuki T.. NSUN3 methylase initiates 5-formylcytidine biogenesis in human mitochondrial tRNAMet. Nat. Chem. Biol. 2016; 12:546–551. [DOI] [PubMed] [Google Scholar]
  • 16. Van Haute L., Dietmann S., Kremer L., Hussain S., Pearce S.F., Powell C.A., Rorbach J., Lantaff R., Blanco S., Sauer S. et al.. Deficient methylation and formylation of mt- tRNAMet wobble cytosine in a patient carrying mutations in NSUN3. Nat. Commun. 2016; 7:12039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. El Yacoubi B., Bailly M., de Crecy-Lagard V.. Biosynthesis and function of posttranscriptional modifications of transfer RNAs. Annu. Rev. Genet. 2012; 46:69–95. [DOI] [PubMed] [Google Scholar]
  • 18. Meng F.L., Cang X.H., Peng Y.Y., Li R.H., Zhang Z.Y., Li F.S., Fan Q.Q., Guan A.S., Fischel-Ghosian N., Zhao X.L. et al.. Biochemical evidence for a nuclear modifier allele (A10S) in TRMU (Methylaminomethyl-2-thiouridylate-methyltransferase) related to mitochondrial tRNA modification in the phenotypic manifestation of deafness-associated 12S rRNA mutation. J. Biol. Chem. 2017; 292:2881–2892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Umeda N., Suzuki T., Yukawa M., Ohya Y., Shindo H., Watanabe K., Suzuki T.. Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs. Implications for the molecular pathogenesis of human mitochondrial diseases. J. Biol. Chem. 2005; 280:1613–1624. [DOI] [PubMed] [Google Scholar]
  • 20. Li X., Li R., Lin X., Guan M.X.. Isolation and characterization of the putative nuclear modifier gene MTO1 involved in the pathogenesis of deafness-associated mitochondrial 12 S rRNA A1555G mutation. J. Biol. Chem. 2002; 277:27256–27264. [DOI] [PubMed] [Google Scholar]
  • 21. Li R., Li X., Yan Q., Qin Mo J., Guan M.X.. Identification and characterization of mouse MTO1 gene related to mitochondrial tRNA modification. Biochim. Biophys. Acta. 2003; 1629:53–59. [DOI] [PubMed] [Google Scholar]
  • 22. Li X., Guan M.X.. A human mitochondrial GTP binding protein related to tRNA modification may modulate phenotypic expression of the deafness-associated mitochondrial 12S rRNA mutation. Mol. Cell. Biol. 2002; 22:7701–7711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Suzuki T., Nagao A., Suzuki T.. Human mitochondrial tRNAs: biogenesis, function, structural aspects, and diseases. Annu. Rev. Genet. 2011; 45:299–329. [DOI] [PubMed] [Google Scholar]
  • 24. Zhang X., Cozen A.E., Liu Y., Chen Q., Lowe T.M.. Small RNA modifications: integral to function and disease. Trends. Mol. Med. 2016; 22:1025–1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Bohnsack M.T., Sloan K.E.. The mitochondrial epitranscriptome: the roles of RNA modifications in mitochondrial translation and human disease. Cell Mol. Life Sci. 2018; 75:241–260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Kirino Y., Goto Y., Campos Y., Arenas J., Suzuki T.. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease. Proc. Natl. Acad. Sci. U.S.A. 2005; 102:7127–7132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Yasukawa T., Suzuki T., Ueda T., Ohta S., Watanabe K.. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAsLeu(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J. Biol. Chem. 2000; 275:4251–4257. [DOI] [PubMed] [Google Scholar]
  • 28. Zeharia A., Shaag A., Pappo O., Mager-Heckel A.M., Saada A., Beinat M., Karicheva O., Mandel H., Ofek N., Segel R. et al.. Acute infantile liver failure due to mutations in the TRMU gene. Am. J. Hum. Genet. 2009; 85:401–407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Guan M.X., Yan Q., Li X., Bykhovskaya Y., Gallo-Teran J., Hajek P., Umeda N., Zhao H., Garrido G., Mengesha E. et al.. Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am. J. Hum. Genet. 2006; 79:291–302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Ghezzi D., Baruffini E., Haack T.B., Invernizzi F., Melchionda L., Dallabona C., Strom T.M., Parini R., Burlina A.B., Meitinger T. et al.. Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. Am. J. Hum. Genet. 2012; 90:1079–1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Baruffini E., Dallabona C., Invernizzi F., Yarham J.W., Melchionda L., Blakely E.L., Lamantea E., Donnini C., Santra S., Vijayaraghavan S. et al.. MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast. Hum. Mutat. 2013; 34:1501–1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Kopajtich R., Nicholls T.J., Rorbach J., Metodiev M.D., Freisinger P., Mandel H., Vanlander A., Ghezzi D., Carrozzo R., Taylor R.W. et al.. Mutations in GTPBP3 cause a mitochondrial translation defect associated with hypertrophic cardiomyopathy, lactic acidosis, and encephalopathy. Am. J. Hum. Genet. 2014; 95:708–720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Kohda M., Tokuzawa Y., Kishita Y., Nyuzuki H., Moriyama Y., Mizuno Y., Hirata T., Yatsuka Y., Yamashita-Sugahara Y., Nakachi Y. et al.. A comprehensive genomic analysis reveals the genetic landscape of mitochondrial respiratory chain complex deficiencies. PLoS Genet. 2016; 12:e1005679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Taylor R.W., Pyle A., Griffin H., Blakely E.L., Duff J., He L., Smertenko T., Alston C.L., Neeve V.C., Best A. et al.. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. JAMA. 2014; 312:68–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Martinez-Zamora A., Meseguer S., Esteve J.M., Villarroya M., Aguado C., Enriquez J.A., Knecht E., Armengod M.E.. Defective expression of the mitochondrial-tRNA modifying enzyme GTPBP3 triggers AMPK-mediated adaptive responses involving complex I assembly factors, uncoupling protein 2, and the mitochondrial pyruvate carrier. PLos One. 2015; 10:e0144273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Chen D., Li F., Yang Q., Tian M., Zhang Z., Zhang Q., Chen Y., Guan M.X.. The defective expression of gtpbp3 related to tRNA modification alters the mitochondrial function and development of zebrafish. Int. J. Biochem. Cell Biol. 2016; 77:1–9. [DOI] [PubMed] [Google Scholar]
  • 37. Westerfield M. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio). 2000; Eugene: University of Oregon Press. [Google Scholar]
  • 38. Kimmel C.B., Ballard W.W., Kimmel S.R., Ullmann B., Schilling T.F.. Stages of embryonic development of the zebrafish. Dev. Dyn. 1995; 203:253–310. [DOI] [PubMed] [Google Scholar]
  • 39. Gonzales A.P., Yeh J.R.. Cas9-based genome editing in zebrafish. Methods Enzymol. 2014; 546:377–413. [DOI] [PubMed] [Google Scholar]
  • 40. Wang X., Yan Q., Guan M.X.. Combination of the loss of cmnm5U34 with the lack of s2U34 modifications of tRNALys, tRNAGlu, and tRNAGln altered mitochondrial biogenesis and respiration. J. Mol. Biol. 2010; 395:1038–1048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Shigi N., Suzuki T., Tamakoshi M., Oshima T., Watanabe K.. Conserved bases in the T Psi C loop of tRNA are determinants for thermophile-specific 2-thiouridylation at position 54. J. Biol. Chem. 2002; 277:39128–39135. [DOI] [PubMed] [Google Scholar]
  • 42. Zhang Q., Zhang L., Chen D., He X., Yao S., Zhang Z., Chen Y., Guan M.X.. Deletion of Mtu1 (Trmu) in Zebrafish revealed the essential role of tRNA modification in mitochondrial biogenesis and hearing function. Nucleic Acids Res. 2018; 46:10930–10945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Broughton R.E., Milam J.E., Roe B.A.. The complete sequence of the zebrafish (Danio rerio) mitochondrial genome and evolutionary patterns in vertebrate mitochondrial DNA. Genome Res. 2001; 11:1958–1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Gong S., Peng Y., Jiang P., Wang M., Fan M., Wang X., Zhou H., Li H., Yan Q., Huang T. et al.. A deafness-associated tRNAHis mutation alters the mitochondrial function, ROS production and membrane potential. Nucleic Acids Res. 2014; 42:8039–8048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Jiang P., Wang M., Xue L., Xiao Y., Yu J., Wang H., Yao J., Liu H., Peng Y., Liu H. et al.. A hypertension-associated tRNAAla mutation alters tRNA metabolism and mitochondrial function. Mol. Cell Biol. 2016; 36:1920–1930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Zhou M., Xue L., Chen Y., Li H., He Q., Wang B., Meng F., Wang M., Guan M.X.. A hypertension-associated mitochondrial DNA mutation introduces an m1G37 modification into tRNAMet, altering its structure and function. J. Biol. Chem. 2018; 293:1425–1438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Enriquez J.A., Attardi G.. Analysis of aminoacylation of human mitochondrial tRNAs. Methods Enzymol. 1996; 264:183–196. [DOI] [PubMed] [Google Scholar]
  • 48. Wang M., Zhou X.L., Liu R.J., Fang Z.P., Zhou M., Eriani G., Wang E.D.. Multilevel functional and structural defects induced by two pathogenic mitochondrial tRNA mutations. Biochem J. 2013; 453:455–465. [DOI] [PubMed] [Google Scholar]
  • 49. Jia Z., Zhang Y., Li Q., Ye Z., Liu Y., Fu C., Cang X., Wang M., Guan M.X.. A coronary artery disease-associated tRNAThr mutation altered mitochondrial function, apoptosis and angiogenesis. Nucleic Acids Res. 2019; 47:2056–2074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Jha P., Wang X., Auwerx J.. Analysis of mitochondrial respiratory chain super-complexes using blue native polyacrylamide gel electrophoresis (BN-PAGE). Curr. Protoc. Mouse Biol. 2016; 6:1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Birch-Machin M.A., Turnbull D.M.. Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol. 2001; 65:97–117. [DOI] [PubMed] [Google Scholar]
  • 52. Zhang J., Ji Y., Lu Y., Fu R., Xu M., Liu X., Guan M.X.. Leber's hereditary optic neuropathy (LHON)-associated ND5 12338T > C mutation altered the assembly and function of complex I, apoptosis and mitophagy. Hum. Mol. Genet. 2018; 27:1999–2011. [DOI] [PubMed] [Google Scholar]
  • 53. Phillips M.J., Webb-Wood S., Faulkner A.E., Jabbar S.B., Biousse V., Newman N.J., Do V.T., Boatright J.H., Wallace D.C., Pardue M.T.. Retinal function and structure in Ant1-deficient mice. Invest. Ophthalmol. Vis. Sci. 2010; 51:6744–6752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Ross J.M. Visualization of mitochondrial respiratory function using cytochrome c oxidase. /succinate dehydrogenase (COX/SDH) double-labeling histochemistry. J. Vis. Exp. 2011; 23:e3266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Moens C. Whole mount RNA in situ hybridization on zebrafish embryos: hybridization. CSH Protoc. 2008; doi:10.1101/pdb.prot5037. [DOI] [PubMed] [Google Scholar]
  • 56. Moens C. Whole mount RNA in situ hybridization on zebrafish embryos: mounting. CSH Protoc. 2008; doi:10.1101/pdb.prot5038. [DOI] [PubMed] [Google Scholar]
  • 57. Moens C. Whole mount RNA in situ hybridization on zebrafish embryos: probe synthesis. CSH Protoc. 2008; doi:10.1101/pdb.prot5036. [DOI] [PubMed] [Google Scholar]
  • 58. Berdougo E., Coleman H., Lee D.H., Stainier D.Y.R., Yelon D.. Mutation of weak atrium/atrial myosin heavy chain disrupts atrial function and influences ventricular morphogenesis in zebrafish. Development. 2003; 130:6121–6129. [DOI] [PubMed] [Google Scholar]
  • 59. Manalo T., May A., Quinn J., Lafontant D.S., Shifatu O., He W., Gonzalez-Rosa J.M., Burns G.C., Burns C.E., Burns A.R. et al.. Differential lectin binding patterns identify distinct heart regions in giant danio (Devario aequipinnatus) and Zebrafish (Danio rerio) Hearts. J. Histochem. Cytochem. 2016; 64:687–714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Huang C.J., Tu C.T., Hsiao C.D., Hsieh F.J., Tsai H.J.. Germ-line transmission of a myocardium-specific GFP transgene reveals critical regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish. Dev. Dyn. 2003; 228:30–40. [DOI] [PubMed] [Google Scholar]
  • 61. Sasagawa S., Nishimura Y., Okabe S., Murakami S., Ashikawa Y., Yuge M., Kawaguchi K., Kawase R., Okamoto R., Ito M. et al.. Downregulation of GSTK1 is a common mechanism underlying hypertrophic cardiomyopathy. Front. Pharmacol. 2016; 7:162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Schneider C.A., Rasband W.S., Eliceiri K.W.. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 2012; 9:671–675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Helm M., Brule H., Degoul F., Cepanec C., Leroux J.P., Giege R, Florentz C.. The presence of modified nucleotides is required forcloverleaf folding of a human mitochondrial tRNA. NucleicAcids Res. 1998; 26:1636–1643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Goto-Ito S., Ito T., Kuratani M., Bessho Y., Yokoyama S.. Tertiary structure ERAL1 levels checkpoint at anticodon loopmodification in tRNA functional maturation. Nat.Struct. Mol. Biol. 2009; 16:1109–1115. [DOI] [PubMed] [Google Scholar]
  • 65. Szczepanowska K., Maiti P., Kukat A., Hofsetz E., Nolte H., Senft K., Becker C., Ruzzenente B., Hornig-Do H.T., Wibom R. et al.. CLPP coordinatesmitoribosomal nucleotides is required for cloverleaf folding of a human mitochondrial tRNA assembly through the regulation of ERAL1 levels. EMBO J. 2016; 35:2566–2583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Nolden M., Ehses S., Koppen M., Bernacchia A., Rugarli E.I., Langer T.. The m-AAA maturation proteasedefective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell. 2005; 123:277–289. [DOI] [PubMed] [Google Scholar]
  • 67. Ma Y.Y., Zhang X.L., Wu T.F., Liu Y.P., Wang Q., Zhang Y., Song J.Q., Wang Y.J., Yang Y.L.. Analysis of the mitochondrial complex I-V enzyme activities of peripheral leukocytes in oxidative phosphorylation disorders. J. Child. Neurol. 2011; 26:974–979. [DOI] [PubMed] [Google Scholar]
  • 68. Zhang J., Jiang P., Jin X., Liu X., Zhang M., Xie S., Gao M., Zhang S., Sun Y.H., Zhu J. et al.. Leber's hereditary optic neuropathy caused by the homoplasmic ND1 m.3635G>A mutation in nine Han Chinese families. Mitochondrion. 2014; 18:18–26. [DOI] [PubMed] [Google Scholar]
  • 69. Hu N., Sedmera D., Yost H.J., Clark E.B.. Structure and function of the developing zebrafish heart. Anat. Rec. 2000; 260:148–157. [DOI] [PubMed] [Google Scholar]
  • 70. Brown DR, S.L. Qian L, Liu J.. Advances in the study of heart development and disease using zebrafish. J. Cardiovasc. Dev. Dis. 2016; 3:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Stainier D.Y. Zebrafish genetics and vertebrate heart formation. Nat. Rev. Genet. 2001; 2:39–48. [DOI] [PubMed] [Google Scholar]
  • 72. Glickman N.S., Yelon D.. Cardiac development in zebrafish: coordination of form and function. Semin. Cell Dev. Biol. 2002; 13:507–513. [DOI] [PubMed] [Google Scholar]
  • 73. Poon K.L., Liebling M., Kondrychyn I., Brand T., Korzh V.. Development of the cardiac conduction system in zebrafish. Gene Expr. Patterns. 2016; 21:89–96. [DOI] [PubMed] [Google Scholar]
  • 74. Becker J.R., Chatterjee S., Robinson T.Y., Bennett J.S., Panakova D., Galindo C.L., Zhong L., Shin J.T., Coy S.M., Kelly A.E. et al.. Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development. Development. 2014; 141:335–345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. John S.W., Krege J.H., Oliver P.M., Hagaman J.R., Hodgin J.B., Pang S.C., Flynn T.G., Smithies O.. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science. 1995; 267:679–681. [DOI] [PubMed] [Google Scholar]
  • 76. Tamura N., Ogawa Y., Chusho H., Nakamura K., Nakao K., Suda M., Kasahara M., Hashimoto R., Katsuura G., Mukoyama M. et al.. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc. Natl. Acad. Sci. U.S.A. 2000; 97:4239–4244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Li X., Guan M.X.. Identification and characterization of mouse GTPBP3 gene encoding a mitochondrial GTP-binding protein involved in tRNA modification. Biochem. Biophys. Res. Commun. 2003; 312:747–754. [DOI] [PubMed] [Google Scholar]
  • 78. Villarroya M., Prado S., Esteve J.M., Soriano M.A., Aguado C., Pérez-Martínez D., Martínez-Ferrandis J.I., Yim L., Victor V.M., Cebolla E. et al.. Characterization of human GTPBP3, a GTP-binding protein involved in mitochondrial tRNA modification. Mol. Cell. Biol. 2008; 28:7514–7531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Moukadiri I., Garzon M.J., Bjork G.R., Armengod M.E.. The output of the tRNA modification pathways controlled by the Escherichia coli MnmEG and MnmC enzymes depends on the growth conditions and the tRNA species. Nucleic Acids Res. 2014; 42:2602–2623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Belostotsky R., Frishberg Y., Entelis N.. Human mitochondrial tRNA quality control in health and disease: a channelling mechanism?. RNA Biol. 2012; 9:33–39. [DOI] [PubMed] [Google Scholar]
  • 81. Nedialkova D.D., Leidel S.A.. Optimization of codon translation rates via tRNA modifications maintains proteome integrity. Cell. 2015; 161:1606–1618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Bullwinkle T.J., Ibba M.. Translation quality control is critical for bacterial responses to amino acid stress. Proc. Natl. Acad. Sci. U.S.A. 2016; 113:2252–2257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Kurata S., Weixlbaumer A., Ohtsuki T., Shimazaki T., Wada T., Kirino Y., Takai K., Watanabe K., Ramakrishnan V., Suzuki T.. Modified uridines with C5-methylene substituents at the first position of the tRNA anticodon stabilize U.G wobble pairing during decoding. J. Biol. Chem. 2008; 283:18801–18811. [DOI] [PubMed] [Google Scholar]
  • 84. Reverendo M., Soares A.R., Pereira P.M., Carreto L., Ferreira V., Gatti E., Pierre P., Moura G.R., Santos M.A.. tRNA mutations that affect decoding fidelity deregulate development and the proteostasis network in zebrafish. RNA Biol. 2014; 11:1199–1213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Gingold H., Pilpel Y.. Determinants of translation efficiency and accuracy. Mol. Syst. Biol. 2011; 7:481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Phizicky E.M., Hopper A.K.. tRNA biology charges to the front. Genes Dev. 2010; 24:1832–1860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Dogan S.A., Pujol C., Maiti P., Kukat A., Wang S., Hermans S., Senft K., Wibom R., Rugarli E.I., Trifunovic A.. Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart. Cell Metab. 2014; 19:458–469. [DOI] [PubMed] [Google Scholar]
  • 88. Detmer S.A., Chan D.C.. Functions and dysfunctions of mitochondrial dynamics. Nat. Rev. Mol. Cell. Biol. 2007; 8:870–879. [DOI] [PubMed] [Google Scholar]
  • 89. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005; 39:359–407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Martínez-Zamora A., Meseguer S., Esteve J.M., Villarroya M., Aguado C., Enríquez J.A., Knecht E., Armengod M.E.. Defective expression of the Mitochondrial-tRNA modifying enzyme GTPBP3 triggers AMPK-Mediated adaptive responses involving complex i assembly factors, uncoupling protein 2, and the mitochondrial pyruvate carrier. PLoS One. 2015; 10:e0144273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Dvornikov A.V., de Tombe P.P., Xu X.. Phenotyping cardiomyopathy in adult zebrafish. Prog. Biophys. Mol. Biol. 2018; 138:116–125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92. Maron B.J., Maron M.S.. Hypertrophic cardiomyopathy. Lancet. 2013; 381:242–255. [DOI] [PubMed] [Google Scholar]
  • 93. Varma P.K., Neema P.K.. Hypertrophic cardiomyopathy: part 1- introduction, pathology and pathophysiology. Ann. Card. Anaesth. 2014; 17:118–124. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

gkz218_Supplemental_Files

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES